Bengaluru-based biopharmaceutical company Biocon has inked a pact with Brazil-based Biomm SA to commercialize its diabetes treatment in the Latin American nation. As per the MoU, Biocon will focus on developing, manufacturing, and supplying Semaglutide (generic: Ozempic)—a drug used to improve glycemic control in adults with type-2 diabetes. Meanwhile, Biomm will be in charge of obtaining regulatory approval and launching the drug in the Brazilian market.

Why Biocon opted for Biomm for its latest strategic vision?

Biomm is Brazil’s first and only biotechnology-focused company that aims to provide high-quality healthcare to patients with chronic conditions and enhance access to advanced treatments. The firm has a dedicated production facility in Brazil’s Nova Lima to develop, manufacture, and commercialize complex biotech and biosimilar medicinal products.

While highlighting the partnership with Biomm, Siddharth Mittal—CEO and MD of Biocon—stated that this collaborative approach is crucial to broadening their horizons beyond the US and Europe, according to a recent statement. He also mentioned that Biocon’s upcoming growth plans are aligned with this partnership, which includes launching a range of intricate GLP-1 drug-device combination products.

Heraldo Marchezini, CEO of Biomm, emphasized Brazil as the fifth most affected nation globally in terms of diabetes prevalence, with 16.8 million adults between the ages of 20 and 79 living with diabetes. Therefore, the firm has been actively pursuing strategic partnerships to advance diabetic care and substantially improve the quality of life for those impacted by the disease.

If you’re associated with the pharmaceutical domain and want to stay updated on crucial insights in the healthcare sector, either fill out the form below or email us at contact@iebrain.com to reach out to experts.

About Ingenious e-Brain

Ingenious e-Brain provides high-quality, customized, and cost-effective Technology Research, Business Research, and Intellectual Property Research solutions to industry leaders and innovative companies across the globe. Innovation, knowledge, and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide the highest quality results ensuring fool-proof confidentiality and security. We are an ISO-certified company with offices in India and USA.

Ingenious e-Brain has a strong team of analysts and subject matter experts with domain proficiency which is devoted to helping clients grow. Our highly qualified professionals offer tailored, value-added, and cost-effective services to our clients. We believe in building long-term relationships with our clients which include national and international corporations, Fortune 500 companies, the world’s leading research institutes and universities as well as independent inventors.